Irbesartan Hct 12.5 mg (Hydrochlorothiazide TABLET) 12.5 MG

Irbesartan HCT 12.5 MG tablets combine irbesartan and hydrochlorothiazide for blood pressure management. This oral medication is designed to support cardiovascular health by combining two active ingredients.

Strength

12.5 MG

Pack Size

100/500

Manufacturer / TM Owner

SIVEM PHARMACEUTICALS ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Irbesartan HCT 12.5 MG tablets are commonly used to manage high blood pressure. The combination of irbesartan, an angiotensin II receptor blocker, and hydrochlorothiazide, a diuretic, works to lower blood pressure by relaxing blood vessels and reducing fluid retention. This medication is often prescribed for individuals who require dual-action therapy to achieve optimal blood pressure control.

Side Effects

Common effects of Irbesartan HCT 12.5 MG tablets may include dizziness, fatigue, and mild nausea. Some users might experience changes in electrolyte levels due to the diuretic component. It's important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Precautions & Warnings

Handle Irbesartan HCT 12.5 MG tablets with care, especially if you have kidney issues or are pregnant. Regular monitoring of blood pressure and electrolyte levels is advisable. Always follow the guidance of a healthcare professional when starting or adjusting this medication.

Avoid Interactions

Irbesartan HCT 12.5 MG tablets may interact with other blood pressure medications, NSAIDs, and certain supplements. Alcohol can enhance the effects of this medication, so moderation is recommended. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Irbesartan HCT 12.5 MG tablets are used to manage high blood pressure by combining irbesartan and hydrochlorothiazide.

Store Irbesartan HCT 12.5 MG tablets at room temperature, away from moisture and heat.

Consult your healthcare provider before combining Irbesartan HCT 12.5 MG with other medications to avoid potential interactions.

Common side effects may include dizziness, fatigue, and mild nausea.

Pregnant individuals should consult a healthcare provider before using Irbesartan HCT 12.5 MG, as it may not be suitable.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.